BHC
Bausch Health Companies Inc. NYSE Listed Mar 29, 1994$4.77
+0.21%
vs $4.76
Mkt Cap $1.8B
52w Low $4.76
0.3% of range
52w High $8.34
50d MA $5.43
200d MA $6.11
P/E (TTM)
11.6x
EV/EBITDA
6.8x
P/B
4.7x
Debt/Equity
-38.4x
ROE
-28.3%
P/FCF
1.8x
RSI (14)
31.40
ATR (14)
$0.21
Beta
0.40
50d MA
$5.43
200d MA
$6.11
Avg Volume
1.9M
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, Ortho Dermatologics, and Diversified Products. The Bausch + Lomb segment offers products with a focus on the vision care, surgical, and consumer, surgical, and ophthalmic pharmaceuticals products. The Salix segment provides gastroenterology products in the United States. The International Rx segment offers Solta products, branded and generic pharmaceutical products, OTC products, and medical device products, and Bausch + Lomb products in Canada, Europe, Asia, Australia, Latin America, Africa, and the Middle East. The Ortho Dermatologics segment provides dermatological products in the United States; and Solta medical aesthetic devices internationally. The Diversified Products segment offers pharmaceutical products in the areas of neurology and other therapeutic classes, as well as generic and dentistry products in the United States. The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018. Bausch Health Companies Inc. is headquartered in Laval, Canada.
2150 St. ElzEar Boulevard West · Laval, QC H7L 4A8 · CA
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 29, 2026 | AMC | 0.81 | 0.78 | -3.7% | 5.59 | +4.7% | +2.3% | -1.2% | -2.1% | +2.0% | +0.2% | — |
| Feb 18, 2026 | AMC | 1.21 | 1.08 | -10.7% | 6.19 | -7.8% | -4.2% | +3.4% | -2.4% | +0.7% | +1.5% | — |
| Oct 29, 2025 | AMC | 1.07 | 1.16 | +8.4% | 5.90 | +6.8% | +12.0% | +6.2% | -3.0% | -1.0% | +0.6% | — |
| Jul 30, 2025 | AMC | 0.97 | 0.90 | -7.2% | 6.39 | -9.7% | -7.8% | -3.1% | +1.2% | +2.8% | -3.0% | — |
| Apr 30, 2025 | AMC | 0.83 | 0.59 | -28.9% | 5.30 | -1.9% | +0.0% | +2.3% | -9.0% | -3.9% | -0.8% | — |
| Feb 19, 2025 | AMC | 1.65 | 1.15 | -30.3% | 6.51 | +6.9% | +10.3% | +1.8% | -1.9% | +5.2% | +2.1% | — |
| Oct 30, 2024 | AMC | 1.03 | 1.12 | +8.7% | 8.17 | +3.7% | +12.6% | +6.3% | -5.3% | +4.6% | -2.0% | — |
| Aug 1, 2024 | AMC | 0.88 | 0.89 | +1.1% | 6.10 | -10.7% | -7.7% | -7.1% | +3.1% | -3.2% | +5.0% | — |
| May 2, 2024 | AMC | 0.75 | 0.59 | -21.3% | 8.09 | +0.1% | -3.3% | -3.8% | -1.5% | -5.1% | -1.1% | — |
| Feb 22, 2024 | AMC | 1.01 | 1.15 | +13.9% | 9.30 | +0.5% | -1.3% | -2.1% | +2.1% | +0.2% | +2.1% | — |
| Nov 2, 2023 | AMC | 0.92 | 1.03 | +12.0% | 7.34 | +1.1% | +3.1% | -1.6% | -2.7% | -1.1% | -4.6% | — |
| Aug 3, 2023 | AMC | 0.75 | 0.81 | +8.0% | 9.41 | +1.2% | -3.7% | -2.5% | +0.8% | -3.1% | -2.4% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 27 | RBC Capital | Maintains | Sector Perform → Sector Perform | — | $5.63 | $5.62 | -0.2% | -0.9% | +1.6% | -1.4% | +2.3% | -1.2% |
| Feb 25 | Barclays | Maintains | Equal Weight → Equal Weight | — | $6.02 | $6.10 | +1.3% | +1.5% | -1.1% | -1.8% | +0.3% | -3.7% |
| Jan 7 | Truist | Maintains | Hold → Hold | — | $7.63 | $7.71 | +1.0% | +3.5% | -1.6% | -4.6% | +1.1% | +0.1% |
| May 2 | RBC Capital | Maintains | Sector Perform → Sector Perform | — | $5.30 | $5.42 | +2.3% | +2.3% | -9.0% | -3.9% | -0.8% | +0.0% |
| Feb 6 | Jefferies | Downgrade | Buy → Hold | — | $7.34 | $7.30 | -0.5% | -10.9% | -1.4% | -2.0% | +0.8% | -0.2% |
| Jan 30 | RBC Capital | Maintains | Sector Perform → Sector Perform | — | $7.47 | $7.50 | +0.4% | -0.1% | -0.4% | -2.0% | -0.3% | +1.1% |
| Nov 1 | RBC Capital | Maintains | Sector Perform → Sector Perform | — | $9.20 | $9.31 | +1.2% | +6.3% | -5.3% | +4.6% | -2.0% | -0.8% |
| Aug 2 | Piper Sandler | Downgrade | Neutral → Underweight | — | $6.10 | $5.45 | -10.7% | -7.7% | -7.1% | +3.1% | -3.2% | +5.0% |
| Aug 2 | RBC Capital | Maintains | Sector Perform → Sector Perform | — | $6.10 | $5.45 | -10.7% | -7.7% | -7.1% | +3.1% | -3.2% | +5.0% |
| Jul 25 | Truist | Maintains | Hold → Hold | — | $5.81 | $5.77 | -0.7% | +1.2% | +1.9% | -0.7% | +0.2% | +1.2% |
| Apr 23 | RBC Capital | Maintains | Sector Perform → Sector Perform | — | $8.45 | $8.50 | +0.6% | +0.9% | +0.4% | +0.7% | +1.0% | +2.0% |
| Apr 12 | RBC Capital | Maintains | Sector Perform → Sector Perform | — | $8.97 | $8.84 | -1.4% | -2.3% | -1.5% | +1.3% | -0.9% | -0.7% |
| Apr 5 | RBC Capital | Maintains | Sector Perform → Sector Perform | — | $10.05 | $10.07 | +0.2% | +3.6% | -6.9% | -4.4% | -3.7% | +0.6% |
| Feb 23 | RBC Capital | Maintains | Sector Perform → Sector Perform | — | $9.30 | $9.35 | +0.5% | -1.3% | -2.1% | +2.1% | +0.2% | +2.1% |
| Sep 20 | Jefferies | Upgrade | Hold → Buy | — | $7.72 | $8.68 | +12.4% | +8.0% | +0.6% | -2.0% | +0.4% | -0.2% |
| Jun 16 | TD Cowen | Downgrade | Outperform → Market Perform | — | $7.44 | $7.24 | -2.7% | -1.2% | +0.7% | -0.4% | -0.5% | -1.9% |
| May 22 | Jefferies | Maintains | Buy → Buy | — | $8.30 | $8.46 | +1.9% | +6.0% | -4.4% | -1.5% | -1.0% | -0.7% |
| May 5 | RBC Capital | Maintains | Sector Perform → Sector Perform | — | $5.89 | $5.96 | +1.2% | -1.0% | +2.7% | -2.2% | +1.5% | -2.2% |
| Sep 9 | Piper Sandler | Maintains | Neutral → Neutral | — | $6.70 | $6.71 | +0.1% | +10.4% | -1.9% | +1.4% | +6.7% | -2.7% |
| Sep 1 | RBC Capital | Maintains | Sector Perform → Sector Perform | — | $5.97 | $5.76 | -3.5% | +10.4% | -2.1% | +0.6% | +7.1% | -3.6% |
| Aug 10 | RBC Capital | Maintains | Sector Perform → Sector Perform | — | $5.18 | $5.32 | +2.7% | +9.1% | +9.7% | -3.1% | +4.5% | +1.3% |
| Aug 10 | BMO Capital | Maintains | Market Perform → Market Perform | — | $5.18 | $5.32 | +2.7% | +9.1% | +9.7% | -3.1% | +4.5% | +1.3% |
| Jul 29 | JP Morgan | Downgrade | Overweight → Neutral | — | $5.10 | $5.11 | +0.2% | -9.4% | -0.6% | -0.2% | +13.5% | -1.5% |
| Jul 29 | RBC Capital | Downgrade | Outperform → Sector Perform | — | $5.10 | $5.11 | +0.2% | -9.4% | -0.6% | -0.2% | +13.5% | -1.5% |
| Jul 29 | Truist | Downgrade | Buy → Hold | — | $5.10 | $5.11 | +0.2% | -9.4% | -0.6% | -0.2% | +13.5% | -1.5% |
| Jul 26 | RBC Capital | Maintains | Outperform → Outperform | — | $8.84 | $8.76 | -0.9% | -1.1% | -0.7% | -41.2% | -9.4% | -0.6% |
| May 13 | RBC Capital | Maintains | Outperform → Outperform | — | $10.45 | $10.53 | +0.8% | +3.7% | -0.6% | +2.4% | -9.8% | +2.0% |
| May 9 | RBC Capital | Maintains | Outperform → Outperform | — | $16.04 | $15.68 | -2.2% | -19.6% | -27.1% | +7.8% | +3.2% | +3.7% |
| Nov 3 | RBC Capital | Maintains | Outperform → Outperform | — | $25.87 | $25.98 | +0.4% | +5.3% | -0.7% | +3.4% | +0.9% | -2.5% |
| Oct 1 | Jefferies | Maintains | Buy → Buy | — | $27.85 | $27.94 | +0.3% | +2.7% | -2.1% | +0.4% | -1.8% | +1.2% |
| Jun 3 | Jefferies | Maintains | Buy → Buy | — | $31.89 | $31.80 | -0.3% | -0.6% | -1.1% | +0.9% | -1.1% | -0.1% |
| Mar 24 | BofA Securities | Downgrade | Neutral → Underperform | — | $31.66 | $30.55 | -3.5% | -3.0% | +1.3% | -0.3% | -1.0% | +1.1% |
| Mar 16 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $33.80 | $34.01 | +0.6% | -1.2% | -0.2% | -1.4% | +0.5% | -0.1% |
| Feb 26 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $31.28 | $31.42 | +0.4% | +0.4% | +1.1% | +1.7% | +0.9% | -2.0% |
| Feb 17 | RBC Capital | Upgrade | Sector Perform → Outperform | — | $31.32 | $32.00 | +2.2% | +2.3% | -1.4% | +1.1% | -0.9% | -0.2% |
| Jan 15 | Jefferies | Maintains | Buy → Buy | — | $26.41 | $26.18 | -0.9% | -0.2% | +4.4% | -1.9% | -1.2% | -0.1% |
| Nov 25 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $19.24 | $19.08 | -0.8% | -0.4% | +1.9% | -4.9% | +0.4% | +2.2% |
| Nov 5 | Piper Sandler | Maintains | Overweight → Overweight | — | $16.81 | $17.05 | +1.4% | -0.5% | -0.5% | +15.1% | +1.7% | -0.4% |
| Oct 28 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $17.74 | $17.26 | -2.7% | -5.5% | +0.5% | -2.1% | +5.1% | -6.1% |
| Sep 17 | BofA Securities | Upgrade | Underperform → Neutral | — | $16.88 | $16.94 | +0.4% | +3.0% | -1.1% | -3.9% | -2.9% | -1.9% |
| Aug 24 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $16.39 | $16.74 | +2.1% | +3.4% | +0.0% | +1.8% | -1.5% | -0.5% |
| Aug 19 | Piper Sandler | Maintains | Overweight → Overweight | — | $17.33 | $17.23 | -0.6% | -2.7% | +0.1% | -2.9% | +3.4% | +0.0% |
| Aug 10 | Citigroup | Maintains | Buy → Buy | — | $18.05 | $18.33 | +1.6% | -1.8% | -0.3% | -1.5% | -1.2% | +1.7% |
| Jul 7 | BofA Securities | Maintains | Underperform → Underperform | — | $19.00 | $18.71 | -1.5% | -3.0% | -4.8% | -2.3% | +0.2% | +1.3% |
| Jun 17 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $19.38 | $20.00 | +3.2% | +2.2% | +1.4% | -2.4% | +0.3% | -0.3% |
| May 8 | RBC Capital | Maintains | Sector Perform → Sector Perform | — | $15.87 | $15.81 | -0.4% | +5.9% | +0.4% | +1.7% | -4.6% | -2.6% |
| May 8 | SunTrust Robinson Humphrey | Maintains | Buy → Buy | — | $15.87 | $15.81 | -0.4% | +5.9% | +0.4% | +1.7% | -4.6% | -2.6% |
| May 8 | CFRA | Maintains | Hold → Hold | — | $15.87 | $15.81 | -0.4% | +5.9% | +0.4% | +1.7% | -4.6% | -2.6% |
| Apr 30 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $18.39 | $18.15 | -1.3% | -1.5% | -5.3% | -2.8% | +0.6% | +2.0% |
| Apr 28 | RBC Capital | Maintains | Sector Perform → Sector Perform | — | $18.11 | $18.65 | +3.0% | -3.3% | +5.0% | -1.5% | -5.3% | -2.8% |
| Date | Insider | Title | Type | Shares | Price | Value | Owned After | D1% | D5% |
|---|---|---|---|---|---|---|---|---|---|
| May 19, 2026 | Lee Frank D.Dir | — | Sell | 24,456 | $5.43 | $133K | 49,339 | -0.91% | +0.37% |
8-K · 5.02
!!! Very High
Bausch Health Companies Inc -- 8-K 5.02: Executive Change
Bausch Health amended an executive's 2023 performance stock unit award, affecting 1.14 million PSUs originally scheduled to vest in March 2026, likely reflecting recent leadership changes or compensation restructuring.
Mar 2
8-K
Bausch Health Companies Inc -- 8-K Filing
Bausch Health Companies achieved eleven consecutive quarters of year-over-year revenue and adjusted EBITDA growth excluding Bausch + Lomb, demonstrating sustained operational improvement for investors.
Feb 18
Institutional (13F) — Top 20
All ↗
| # | Manager | Shares | Value | Chg | Period |
|---|---|---|---|---|---|
| 1 | Paulson & Co | 73,255,869 | $396M | New | Mar 2026 |
| 2 | Royal Bank Of Canada | 11,363,498 | $61M | Added | Mar 2026 |
| 3 | Nomura Holdings Inc | 8,986,372 | $49M | Added | Mar 2026 |
| 4 | Healthcare Of Ontario Pension Plan Trust Fund | 8,000,000 | $43M | Reduced | Mar 2026 |
| 5 | Vanguard Capital Management Llc | 7,403,759 | $40M | New | Mar 2026 |
| 6 | Kohlberg Kravis Roberts & Co. L.p. | 5,235,000 | $36M | — | Dec 2025 |
| 7 | Hudson Bay Capital Management Lp | 5,000,000 | $35M | — | Dec 2025 |
| 8 | Mfn Partners Management, Lp | 6,000,000 | $32M | New | Mar 2026 |
| 9 | Acadian Asset Management Llc | 4,879,485 | $26M | Added | Mar 2026 |
| 10 | Nuveen, Llc | 3,798,957 | $20M | Added | Mar 2026 |
| 11 | Morgan Stanley | 2,109,436 | $15M | Added | Dec 2025 |
| 12 | Walleye Capital Llc | 2,354,740 | $13M | Added | Mar 2026 |
| 13 | Private Management Group Inc | 1,703,511 | $9M | Reduced | Mar 2026 |
| 14 | Two Sigma Investments, Lp | 1,578,161 | $9M | Reduced | Mar 2026 |
| 15 | Renaissance Technologies Llc | 1,575,772 | $9M | Added | Mar 2026 |
| 16 | Point72 Asset Management | 1,350,262 | $7M | Reduced | Mar 2026 |
| 17 | Arrowstreet Capital, Limited Partnership | 1,195,217 | $6M | Reduced | Mar 2026 |
| 18 | Qube Research & Technologies Ltd | 1,110,726 | $6M | Added | Mar 2026 |
| 19 | Ubs Group Ag | 1,041,848 | $6M | Added | Mar 2026 |
| 20 | Bank Of Montreal /can/ | 929,431 | $5M | Added | Mar 2026 |
Mutual Funds / ETFs (N-PORT) — Top 20
All ↗
Valuation
Market Cap
$1.77B
Enterprise Value
$21.17B
P/E (TTM)
11.63x
Forward P/E
1.09x
PEG Ratio
-0.04x
P/B
4.70x
P/S
0.17x
P/FCF
1.76x
EV/EBITDA
6.84x
Shares Out
370.5M
Financials (TTM)
Revenue
$10.31B
Net Income
$155.3M
EBITDA
$3.10B
Free Cash Flow
$1.00B
Op Cash Flow
$1.40B
EPS Basic
$0.41
EPS Diluted
$0.41
EPS Forward
$4.37
Gross Margin
68.3%
Op Margin
20.1%
Net Margin
1.5%
Balance Sheet
Total Assets
$26.32B
Total Liab.
$25.94B
Total Equity
$376.3M
Cash
$1.32B
LT Debt
$20.72B
Book Value/Sh
$1.02
Debt/Equity
-38.35x
Current Ratio
1.47
Quick Ratio
1.08
Returns & Growth
ROE
-28.3%
ROA
0.6%
ROIC
3.0%
Rev Growth YoY
+7.1%
EPS Growth YoY
+415.4%
Price Returns
2W
-1.7%
1M
-6.3%
3M
-9.6%
6M
-15.6%
12M
+18.3%
Technicals
52W High
$8.34
52W Low
$4.76
50d MA
$5.43
200d MA
$6.11
RSI (14)
31.40
ATR (14)
$0.21
Beta
0.40
Avg Volume
1.9M
Dividends
Div Rate
$0.00
Div Yield
—
Frequency
—
Ex-Div Date
Nov 10, 2010
Analyst Price Targets
Consensus
$8.00
High
$8.00
Low
$8.00
Median
$8.00
Data updated apr 24, 2026 9:30pm
· Source: financialmodelingprep.com